# Clinical Validation of a Urinary Exosome Gene Signature in Men Presenting for Suspicion of Prostate Cancer

> **NCT02702856** · — · COMPLETED · sponsor: **Exosome Diagnostics, Inc.** · enrollment: 2000 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** ExoIntelliScore Prostate

## Key facts

- **NCT ID:** NCT02702856
- **Lead sponsor:** Exosome Diagnostics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-04
- **Final completion:** 2015-06
- **Target enrollment:** 2000 (ACTUAL)
- **Last updated:** 2016-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02702856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02702856, "Clinical Validation of a Urinary Exosome Gene Signature in Men Presenting for Suspicion of Prostate Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02702856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*